No, small air bubbles in GLP-1 injections administered subcutaneously (under the skin) cannot cause air embolism, as they are absorbed harmlessly by the fatty tissue and do not enter the bloodstream
In mediation analysis, semaglutide was found to have a direct effect on reducing total daily insulin dose by 8.9 U per day to 11.4 U per day, with the largest effect observed at the start of treatment
Semaglutide, a once-weekly GLP-1 receptor agonist, has emerged as an effective therapeutic for its marked weight reduction and cardiometabolic benefits, including reductions in visceral adipose tissue 3,4,5
So, what do you want to do if we construe James not just as a manic episode but as a severe psychotic manic episode thats seriously jeopardizing his fundamental wellbeing and hasnt gotten better with other things
In most cases, side effects are mild and temporary, lasting only a few days to a week
With a dose three times the standard maximum, the core question for practitioners is safety
